- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03824301
Different Modes of Ventilation During Cardiopulmonary Bypass
January 30, 2019 updated by: Ayman Anis Metry, Ain Shams University
Comparative Study Between Different Modes of Ventilation During Cardiopulmonary Bypass and Its Effect on Postoperative Pulmonary Dysfunction
66 patients divided into 3 groups with different modes of ventilation.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Sixty-six patients going through open-heart surgeries were included in the study, divided into 3 groups (P: pressure controlled ventilation, V: volume controlled ventilation, C: control) in accordance with the mode of ventilation.
Patients studied for chest x-ray, lung ultrasound, arterial oxygen partial pressure to fractional inspired oxygen ratio (PaO2/FiO2), Alveolar-arterial oxygen gradient, static lung compliance and dynamic lung compliance, taken after induction of anesthesia, 1h post cardiopulmonary bypass, 1h after arrival to cardiac surgical unit.
Study Type
Interventional
Enrollment (Actual)
66
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Cairo, Egypt
- Ain Shams University cardiothoracic hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients undergoingvalve surgeries
- Patients undergoing coronary artery bypass grafting surgeries
Exclusion Criteria:
- Emergency cases.
- Off-pump surgeries.
- Patients with chronic lung diseases with forced expiratory volume in first second (FEV1) or forced vital capacity (FVC) less than 40% of the predicted value.
- Massive blood transfusion during surgery.
- Complicated surgeries.
- Redo surgeries.
- Patients with decompensated heart failure prior to surgery.
- Patients refusal
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Volume-controlled ventilation
During cardiopulmonary bypass period the patients were ventilated with volume-controlled ventilation
|
Changing modes of ventilation during cardiopulmonary bypass
|
|
Active Comparator: Pressure-controlled ventilation
During cardiopulmonary bypass period the patients were ventilated with pressure-controlled ventilation
|
Applying pressure controlled ventilation during cardiopulmonary bypass Period
|
|
No Intervention: No ventilation
During cardiopulmonary bypass period the patients were disconnected from ventilator
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
chest x-ray
Time Frame: after induction of anesthesia, 1hour post cardiopulmonary bypass and 1hour after arrival to cardiac surgical unit.
|
Chest x ray to detect any lung pathology or changes from baseline like pleural effusion, pulmonary edema or pneumonia
|
after induction of anesthesia, 1hour post cardiopulmonary bypass and 1hour after arrival to cardiac surgical unit.
|
|
lung ultrasonography
Time Frame: after induction of anesthesia, 1hour post cardiopulmonary bypass and 1hour after arrival to cardiac surgical unit.
|
Lung ultrasonography to detect any lung changes from baseline or development of consolidation, pulmonary edema or pleural effusion
|
after induction of anesthesia, 1hour post cardiopulmonary bypass and 1hour after arrival to cardiac surgical unit.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 22, 2017
Primary Completion (Actual)
March 30, 2018
Study Completion (Actual)
November 20, 2018
Study Registration Dates
First Submitted
January 23, 2019
First Submitted That Met QC Criteria
January 30, 2019
First Posted (Actual)
January 31, 2019
Study Record Updates
Last Update Posted (Actual)
January 31, 2019
Last Update Submitted That Met QC Criteria
January 30, 2019
Last Verified
January 1, 2019
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- ASCSH32/17
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.